Phinge Seeks to Facilitate Breakthroughs in Cancer Research with Upcoming Netverse Hardware-Verified, App-less Technologies, Platform & Verified AI

INCLINE VILLAGE, Nev. - Oct. 28, 2025 - PRLog -- Following its recent announcement detailing its upcoming Netverse® platform's potential capabilities for securing clinical trials, Phinge® is highlighting how the same patented, hardware-verified technology can revolutionize research for cancer and other diseases.

By eliminating vulnerable apps and centralizing verification at the device level, Netverse will enable secure, decentralized, and patient-centric studies for treating diseases like cancer. This advancement could address critical challenges in oncology and other research, from data integrity to patient recruitment, ultimately accelerating the development of life-saving therapies.

Netverse's patented app-less technology and hardware-verified identity could offer a new paradigm for research into cancer and other diseases. The decentralized, zero-trust framework will empower researchers to collect highly accurate and private data directly from participants, replacing vulnerable apps with a secure, all-in-one platform. This approach would improve data integrity, enhances patient recruitment, and accelerates the development of new cancer treatments.

Netverse: Reshaping Cancer Research with Verified Technology

Cancer research faces long-standing challenges related to data integrity, patient privacy, and participation. In a traditional research setting, data is often collected through disparate systems and apps, creating vulnerabilities to security breaches and identity fraud. Phinge's Netverse platform is being engineered to address these issues head-on, leveraging its patented hardware to provide a verified, secure, and user-centric experience. https://www.ncbi.nlm.nih.gov/books/NBK233428/

• Secure Remote Monitoring: The app-less architecture will allow participants to securely use Netverse-enabled hardware to provide biometric data, report symptoms, and log treatment adherence without the security risks of traditional mobile apps. This decentralized approach is particularly beneficial for cancer patients who may have limited mobility or live in remote areas, significantly increasing the diversity and scale of clinical trials.
• Enhanced Data Integrity: By verifying participants directly through their Netverse hardware, the platform will ensure that the data is authentic and comes from the intended source. This is a fundamental shift from relying on software-based identity, which is susceptible to tampering. For cancer research, this means higher confidence in reported outcomes, from quality-of-life metrics to treatment-related side effects.
• Patient-Controlled Privacy: With Netverse's decentralized, zero-trust model, each participant would retain ownership and control over their data. This model will build trust with patients, who may be hesitant to share sensitive health information. By giving them full transparency and control over who accesses their data, Netverse can increase participation and retention in critical cancer studies.

Side-by-Side Comparison: Netverse vs. Traditional Cancer Research

Feature	Traditional Research Methods	Netverse-Enabled Cancer Research
Identity Verification	Relies on software-based authentication and manual identity checks, creating vulnerabilities to fraud.	Will use patented hardware to verify the user's identity, ensuring data authenticity and preventing identity fraud.
Data Collection	Dependent on multiple apps, websites, and in-person visits, leading to fragmented data, security risks, and data entry errors.	Will use a single, app-less platform on Netverse hardware, providing a seamless, secure, and integrated data stream.
Security Model	Centralized, offering a single point of failure and vulnerability to large-scale data breaches.	Decentralized with a zero-trust framework, assuming a breach and verifying every request to protect patient data.
Patient Privacy	Patients may have limited control over who accesses their sensitive health information.	Patient is the sole custodian of their data, with end-to-end encryption and full control over access permissions.
Patient Recruitment & Retention	In-person visit requirements can create barriers for patients, especially those in vulnerable health states or remote areas, potentially limiting study diversity.	Enables remote, decentralized trials, reducing the burden on patients and allowing for broader, more inclusive participant pools.

By providing an app-less, hardware-verified platform, Netverse is poised to transform research for cancer and other diseases. Phinge's Netverse platform's commitment to security, decentralization, and patient empowerment will enable more robust, inclusive, and efficient clinical trials. This move could accelerate the discovery and delivery of new treatments, ultimately improving outcomes for cancer patients worldwide.

"My mom passed away from cancer, so anything that could be done to achieve prevention or find a quicker cure is a primary focus of mine," says Robert DeMaio, Phinge Corporation's Founder and CEO.

Preview Netverse and its patented, magnetically attachable smartphones and devices by visiting Phinge's websites at
https://www.phinge.com

To get on a contact list, please fill out the online form here
https://www.phinge.com/netverseai.html

Ask Google Gemini about Netverse here
https://www.phinge.com/get-netverse.html

View Phinge's Crunchbase profile here
https://www.crunchbase.com/organization/phinge

View Phinge CEO Robert DeMaio's Crunchbase profile here
https://www.crunchbase.com/person/robert-charles-demaio

Phinge CEO Spoke at Strong AI Summit 2025
https://youtu.be/c_du6wniqLY



About Phinge Corporation

Phinge was founded and through Netverse® is being developed to disrupt today's outdated App technologies, including the App-store duopoly, by partnering with and giving its users and businesses ownership and control of their data, enhanced privacy and a better overall mobile experience including their ability to monetize it.

Phinge through its upcoming patented Netverse App-less technology platform with proprietary AI, will be a better, safer, verified and rewarding alternative platform and technology for users and third party businesses and developers to today's App stores, operating systems and ecosystems of Apple, Google and Android.

Netverse will not be an App or Super App that resides on the major technology platforms of today.

Instead, it will be a standalone, all-in-one, app-less platform, accessible only through Phinge's revolutionary, patented, Mobile Hardware which includes Magnetically Attachable/Detachable Phones, Tablets, Mobile Gaming Systems and peripherals like the stylish, wireless earbuds with interchangeable batteries and built-in sensor screens for continuous usage without recharging. Smart Watches that never need to be physically charged as they come with stylish external, interchangeable bezels with built-in rechargeable batteries and come in a variety of colors, patterns and finishes.

Netverse will be a verified, centralized-decentralized platform.

Centralized in the way it provides universal safeguards through verification of all users, businesses, organizations, entities and IP through Phinge's patented Netverse technologies and hardware.

Centralized because Phinge and Netverse will be compliant with all government regulations regarding data and privacy.

Decentralized because all third party platforms will be compliant with all government regulations regarding data and privacy as soon as they are verified and join Netverse.

Decentralized because its users, businesses, organizations and entities will have the power to live, work and thrive in a verified world.

Netverse will benefit all verified users and approved, verified third party businesses, developers and platforms on Netverse in ways not possible with today's technology including total verification of all users, businesses, organizations, platforms.